Tacrolimus 0.2 mg Granules for Oral Suspension
RxNorm 2052605
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2052605 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tacrolimus 0.2 mg Granules for Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Tacrolimus 0.2 mg Granules for Oral Suspension
(Atom ID: 12334840)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely tacrolimus 200 microgram/1 sachet granules for conventional release oral suspension (clinical drug)
(Atom ID: 12666101)
PSNPrescribable
Prescribable Name (PSN):
Tacrolimus 0.2 mg Granules for Oral Suspension
(Atom ID: 10323245)
PTPrescribable
Designated preferred name (PT):
Tacrolimus 200 microgram granules for oral suspension sachet
(Atom ID: 12666307)
Patient Education
Tacrolimus
Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.
[Learn More]
* Please review the disclaimer below.